Same Wallet. Phished Again. $49.8 Million Total, for Those Keeping Score.

We believe Executive Order 14241 has unleashed a potentially huge change to America’s money.

Republican or Democrat – whether you support or oppose Trump’s New Dollar – you could soon be using it.

If you have savings in the bank or a stock portfolio, we believe you need to understand what’s unfolding – and take specific action to prepare.

Here’s everything you need to know:

In Porter Stansberry’s new documentary, you’ll discover:

Watch now: Trump’s New Dollar

LOSS OF THE DAY 🏆

Every day we crown one person who made the worst financial decision on the internet.

Today's winner didn't make a bad trade. They signed a bad transaction. For the second time.

Here's the setup. A crypto whale held roughly $25.6 million in mixed DeFi assets. WBTC, cbBTC, LDO, USDS, and CRV. A diversified portfolio sitting in a single hot wallet.

Then they approved a malicious token contract. One signature. That's all it took.

The attacker drained everything. $25.6 million moved across four separate addresses within minutes. On-chain forensic analysts traced the funds as they were swapped into DAI and ETH.

Here's the thing. This is not the first time.

The same wallet was phished in September 2023 for $24.2 million. They kept $25 million in the same address and got hit again.

Last time, the attacker returned 90% of the funds. This time, they did not.

Total damage across both incidents: $49.8 million from a single wallet address. That's not a hack. That's a subscription service.

What is a malicious token approval? When you interact with a DeFi protocol, you sign a permission letting a smart contract move your tokens. A phishing attack tricks you into signing that permission for an attacker's contract instead. One signature, and they can drain every approved asset from your wallet. You can revoke old approvals on sites like Revoke.cash — but you have to actually do it.

Not everybody can be Loss of the Day. But these two gave it a real shot. Let's run through the tape.

There's a certain kind of stock that sounds incredible in a pitch deck and terrible in an earnings call. u/coolingsystem_bull found one.

Thermaline Corp, ticker $INV, builds companies around breakthrough technologies. Their flagship: a liquid-cooling system for AI data centers.

The pitch was perfect. AI infrastructure is booming. Data centers need cooling. This company does cooling. He bought 24,000 shares at $3.60.

One problem: the earnings call.

Revenue doubled year over year. $953,000, up from $476,000. That sounds good until you realize the company then suspended its own 2026 revenue and cash flow guidance.

The stock dropped 45% after hours to $1.99. By the next session, it was down 55% to $1.61.

His 24,000 shares went from $86,400 to $38,640.

Translation: the CEO said he believes in "the long-term opportunity." That is what CEOs say when the short-term opportunity no longer exists.

u/cf_cure_moonshot went long on Meridian Biotherapeutics, ticker $SION, ahead of Phase 2a trial results for a cystic fibrosis drug candidate.

The stock was trading at $51. He bought 1,800 shares. $91,800 on the line.

The trial results came in. The drug produced a placebo-adjusted change of −1.0 mmol/L in sweat chloride. The p-value was 0.7.

For context: a p-value of 0.7 means the drug performed about as well as doing nothing. A coin flip is more statistically significant.

The stock opened at $4.05. A 92% drop in one session. His $91,800 became $7,290.

Why biotech stocks are binary bets: a drug either works or it doesn't. There is no middle ground. When a clinical trial reports a p-value of 0.7, it means the result is statistically indistinguishable from chance. The stock doesn't dip. It craters. Holding shares through a trial readout is functionally a coin flip with your savings.

After the crash, the company's market cap fell to $183 million. It has $268 million in cash. The stock is now worth less than the money sitting in its own bank account. The market is literally saying the drug pipeline has negative value. That's the part worth understanding.

Every newsletter needs a meme section. Ours just hits different when you're reading it from a wallet that's been drained twice.

If you laughed, you're coping. If you didn't laugh, check your token approvals.

See you tomorrow. Same losses. Different people. Exact same mistakes.